Chief Executive Officer | Novartis

Vasant Narasimhan

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

A man standing in front of the words indiaspora 2 0 2 0 business leaders.

Vasant has been crucial to Novartis’ success since taking the reins as CEO in 2018, realizing $70 billion in strategic transactions. Using therapy platforms and data science, the company aims to drive innovation in the medical field and provide a better quality of life to the communities it serves. Vasant’s career at Novartis has grown from his role as president of the U.S. region for Novartis Vaccines and Diagnostics to Global Head of Drug Development and Chief Medical Officer before being named CEO. Vasant holds a doctor of medicine from Harvard Medical School and has previously worked on public health issues facing low- and middle-income countries.
Vasant is a member of the National Academy of Medicine and serves on the board of fellows for Harvard Medical School. Additionally, he serves on the board of the nonprofit conservation organization, African Parks. In response to the COVID-19 pandemic, Novartis has donated $40 million to support projects and medical infrastructure development around the world.
 

Subscribe to our Newsletter